<DOC>
	<DOCNO>NCT02974816</DOCNO>
	<brief_summary>The purpose study compare HbA1c insulin-treated subject type 2 diabetes manage via usual care alone usual care augment remote monitoring use Glooko</brief_summary>
	<brief_title>Glooko Enabled Remote Monitoring Insulin-treated Patients With Type 2 Diabetes</brief_title>
	<detailed_description>In study , investigator want evaluate diabetes self-management support mobile application , capture subject 's blood glucose reading , lifestyle medication information share subject 's certified diabetes educator ( CDE ) enable remote monitoring , improve glycemic control compare standard care .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Imidacloprid</mesh_term>
	<criteria>1 . Subject voluntarily sign date informed consent form , approve Institutional Review Board/Independent Ethics Committee , provide Health Insurance Portability Accountability Act authorization ( HIPAA ) privacy authorization prior participation study 2 . Subject document type 2 diabetes 3 . Subject HbA1c &gt; /= 8 % &lt; /=11 % measure use NGSP certify method &lt; /= 3 month screen visit 4 . Subject insulin therapy insulin therapy antihyperglycemic agent , include oral hypoglycemic ( OAs ) , non insulin injectables ( e.g . GLP1 ) least 3 month screen visit 5 . Subject ≥ 18 ≤ 75 year age 6 . Subject male nonpregnant , nonlactating female , least 6 week postpartum prior screen visit . A urine pregnancy test require female subject unless childbearing potential , defined postmenopausal least one year prior screen visit surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) 7 . If female childbearing potential , practice one follow method birth control ( continue duration study ) : Condoms , sponge , diaphragm , intrauterine device Oral parenteral contraceptive 3 month prior screen visit Vasectomized partner Total abstinence sexual intercourse 8 . Subject able speak , read write English 9 . Subject smartphone active data plan access WiFi download least one mobile application phone , 10 . Subject own Glooko compatible glucose meter 11 . Subject currently perform selfmonitoring blood glucose ( SMBG ) , confirm obtain least 45 ± 10 SMBG reading &lt; /= 90 day screen visit 1 . Subject myocardial infarction acute coronary syndrome within last three month cardiac abnormality congestive heart failure consider exclusionary study physicians 2 . Subject type 1 diabetes 3 . Subject renal insufficiency ( eGFR &lt; 30 mL/min/1.73 m2 ) evidence kidney disease failure 4 . Subject impaired liver function AST ALT &gt; two time upper limit laboratory 's normal range 5 . Subject chronic contagious , infectious disease Hepatitis B C , tuberculosis HIV ( per documentation medical record ) 6 . Subject glucocorticoid treatment last 3 month prior screen visit 7 . Subject visual impairment limit his/her ability see use mobile application 8 . Subject dementia , opinion principal investigator study physician would result lack cooperation study procedure brain metastasis , history significant neurological psychiatric disorder psychological condition may interfere compliance study protocol procedures 9 . Subject active malignancy current infection require medication hospitalization 10 . Subject life expectancy &lt; 6 month 11 . Subject participant another clinical study approve concomitant study Glooko 12 . Subject condition event consider exclusionary PI cover study physician 13 . Subject body mass index ≥ 40 kg/m2 14 . 14 . Subject drug addiction and/or alcoholism 15 . Subject diagnosis proliferative retinopathy , amputation attributable diabetes , and/or severe peripheral neuropathy would interfere ability participate study 16 . Subject active diabetes foot ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Glooko</keyword>
	<keyword>Mobile health application</keyword>
	<keyword>Insulin treat</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Remote patient monitoring</keyword>
	<keyword>Certified diabetes educator</keyword>
	<keyword>mHealth Advantage</keyword>
	<keyword>Population health</keyword>
</DOC>